ISIS 2922: Patient enrollment is underway in early-stage patients with CMV retinitis, after the Phase III trial was halted temporarily in May due to side effect

Isis Pharmaceuticals Inc. (ISIP), Carlsbad, Calif. Product: ISIS 2922 Indication: CMV retinitis Status: Patient enrollment is underway in early-stage patients with CMV retinitis, after the Phase III ...